ab5089 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab5089 は 50 報の論文で使用されています。

  • Liu Y  et al. Neuronal IFN-beta-induced PI3K/Akt-FoxA1 signalling is essential for generation of FoxA1(+)Treg cells. Nat Commun 8:14709 (2017). IP ; Mouse . PubMed: 28436428
  • Campbell TM  et al. Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy. PLoS One 11:e0168770 (2016). WB . PubMed: 27997592
  • Warrick JI  et al. FOXA1, GATA3 and PPAR? Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines. Sci Rep 6:38531 (2016). PubMed: 27924948
  • Fiorito E  et al. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions. Nucleic Acids Res 44:10588-10602 (2016). ChIP ; Human . PubMed: 27638884
  • Jozwik KM  et al. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. Cell Rep 17:2715-2723 (2016). CHIPseq ; Human . PubMed: 27926873
  • Singhal H  et al. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Sci Adv 2:e1501924 (2016). PubMed: 27386569
  • Miano V  et al. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer. Oncotarget 7:3201-16 (2016). ChIP . PubMed: 26621851
  • Griffon A  et al. Integrative analysis of public ChIP-seq experiments reveals a complex multi-cell regulatory landscape. Nucleic Acids Res 43:e27 (2015). PubMed: 25477382
  • Gosalia N  et al. FOXA2 regulates a network of genes involved in critical functions of human intestinal epithelial cells. Physiol Genomics 47:290-7 (2015). PubMed: 25921584
  • Kerschner JL  et al. Chromatin remodeling mediated by the FOXA1/A2 transcription factors activates CFTR expression in intestinal epithelial cells. Epigenetics 9:557-65 (2014). WB . PubMed: 24440874
  • Sasahara M  et al. Overexpression of androgen receptor and forkhead-box A1 protein in apocrine breast carcinoma. Anticancer Res 34:1261-7 (2014). Human . PubMed: 24596370
  • Caizzi L  et al. Genome-wide activity of unliganded estrogen receptor-a in breast cancer cells. Proc Natl Acad Sci U S A 111:4892-7 (2014). ChIP, WB ; Human . PubMed: 24639548
  • Gosalia N  et al. Architectural proteins CTCF and cohesin have distinct roles in modulating the higher order structure and expression of the CFTR locus. Nucleic Acids Res 42:9612-22 (2014). ChIP ; Human . PubMed: 25081205
  • Ballester B  et al. Multi-species, multi-transcription factor binding highlights conserved control of tissue-specific biological pathways. Elife 3:e02626 (2014). CHIPseq . PubMed: 25279814
  • Dryden NH  et al. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C. Genome Res 24:1854-68 (2014). ChIP . PubMed: 25122612
  • He B  et al. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. Proc Natl Acad Sci U S A 111:18261-6 (2014). PubMed: 25489091
  • Yigit E  et al. Nucleosome mapping across the CFTR locus identifies novel regulatory factors. Nucleic Acids Res 41:2857-68 (2013). ChIP . PubMed: 23325854
  • Caravaca JM  et al. Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes. Genes Dev 27:251-60 (2013). ICC/IF ; Human . PubMed: 23355396
  • Meyer KB  et al. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 93:1046-60 (2013). PubMed: 24290378
  • Robinson JL  et al. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype. Oncogene N/A:N/A (2013). Human . PubMed: 24292680
  • Robbez-Masson LJ  et al. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing. PLoS One 8:e78839 (2013). ChIP . PubMed: 24265722
  • Serandour AA  et al. Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties. Genome Biol 14:R147 (2013). PubMed: 24373287
  • Xiao ZD  et al. Deciphering the transcriptional regulation of microRNA genes in humans with ACTLocater. Nucleic Acids Res 41:e5 (2013). ChIP . PubMed: 22941648
  • Tan PY  et al. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol Cell Biol 32:399-414 (2012). PubMed: 22083957
  • Ross-Innes CS  et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481:389-93 (2012). PubMed: 22217937
  • Cowper-Sal lari R  et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 44:1191-8 (2012). ChIP . PubMed: 23001124
  • Holmes KA  et al. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proc Natl Acad Sci U S A 109:2748-53 (2012). ChIP ; Human . PubMed: 21536917
  • Zhang X  et al. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus. Genome Res 22:1437-46 (2012). PubMed: 22665440
  • Faure AJ  et al. Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. Genome Res 22:2163-75 (2012). PubMed: 22780989
  • Clarke CL & Graham JD Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes. PLoS One 7:e35859 (2012). WB . PubMed: 22545144
  • Kerschner JL & Harris A Transcriptional networks driving enhancer function in the CFTR gene. Biochem J 446:203-12 (2012). WB . PubMed: 22671145
  • Robinson JL  et al. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J 30:3019-27 (2011). PubMed: 21701558
  • Wang D  et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474:390-4 (2011). PubMed: 21572438
  • Hurtado A  et al. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43:27-33 (2011). ChIP ; Human . PubMed: 21151129
  • Sérandour AA  et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res 21:555-65 (2011). ChIP ; Human . PubMed: 21233399
  • Panov AV  et al. Metabolic and functional differences between brain and spinal cord mitochondria underlie different predisposition to pathology. Am J Physiol Regul Integr Comp Physiol 300:R844-54 (2011). PubMed: 21248309
  • Resseguie ME  et al. Aberrant estrogen regulation of PEMT results in choline deficiency-associated liver dysfunction. J Biol Chem 286:1649-58 (2011). PubMed: 21059658
  • Tan SK  et al. AP-2? regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J 30:2569-81 (2011). PubMed: 21572391
  • Malik S  et al. Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM. Mol Cell Biol 30:399-412 (2010). PubMed: 19917725
  • McMullin RP  et al. A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland. Proc Natl Acad Sci U S A 107:98-103 (2010). IHC-P, ChIP ; Mouse . PubMed: 20018680
  • Bernardo GM  et al. FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development 137:2045-54 (2010). ChIP ; Human . PubMed: 20501593
  • Taube JH  et al. Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells. J Biol Chem 285:16135-44 (2010). ChIP ; Mouse . PubMed: 20348100
  • Hua S  et al. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137:1259-71 (2009). ChIP/Chip ; Human . PubMed: 19563758
  • Eeckhoute J  et al. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 19:372-80 (2009). ChIP ; Human . PubMed: 19129543
  • Nucera C  et al. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res 15:3680-9 (2009). WB ; Human . PubMed: 19470727
  • Motallebipour M  et al. Differential binding and co-binding pattern of FOXA1 and FOXA3 and their relation to H3K4me3 in HepG2 cells revealed by ChIP-seq. Genome Biol 10:R129 (2009). ChIP, ChIP/Chip ; Human . PubMed: 19919681
  • Lupien M  et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132:958-70 (2008). ChIP, ChIP/Chip ; Human . PubMed: 18358809
  • Eeckhoute J  et al. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20:2513-26 (2006). WB, ChIP ; Human . PubMed: 16980581
  • Carroll JS  et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43 (2005). PubMed: 16009131
  • Nguyen TT  et al. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol 25:2147-57 (2005). PubMed: 15743813

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録